Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

GLAXOSMITHKLINE PLC (GSK)

159
Delayed Quote. Delayed London Stock Exchange - 11/28 09:19:16 am
1477 GBp   -0.10%
7h ago GLAXOSMITHKLINE : PRESS: Glaxo Fires Executive Who Raised Race Complaint - ..
1d ago GLAXOSMITHKLINE FIRES EXECUTIVE WHO : Bloomberg
1d ago GLAXOSMITHKLINE : Ebola vaccine trial results show promise
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 

GlaxoSmithKline And University Of Nottingham Establish Research Center

04/26/2012 | 04:46am US/Eastern

Drug maker GlaxoSmithKline PLC (>> GlaxoSmithKline plc) and the University of Nottingham said Thursday that they formalized a collaboration to establish a new laboratory to accommodate the Centre of Excellence for sustainable chemistry and to construct an innovative carbon neutral sustainable chemistry laboratory.

MAIN FACTS:

-The Laboratory for Sustainable Chemistry is being supported by a GBP12 million grant from Glaxo.

-Shares at 0829 GMT, down 10 pence, or 0.71%, at 1,403.5 pence valuing the company at GBP71.28 million.

-By Rory Gallivan, Dow Jones Newswires; 44-20-7842-9411; rory.gallivan@dowjones.com

Stocks mentioned in the article : GlaxoSmithKline plc
React to this article
Latest news on GLAXOSMITHKLINE PLC
1h ago GLAXOSMITHKLINE : Ebola Vaccine Seen as Safe in Initial Tests
7h ago GLAXOSMITHKLINE : PRESS: Glaxo Fires Executive Who Raised Race Complaint - Bloom..
1d ago GLAXOSMITHKLINE FIRES EXECUTIVE WHO : Bloomberg
1d ago GLAXOSMITHKLINE : Ebola vaccine trial results show promise
1d ago GLAXOSMITHKLINE : ViiV Healthcare announces new grants in support of ending moth..
1d ago NOVARTIS : FTC Puts Conditions on Pharmaceutical Joint Venture Between GlaxoSmit..
1d ago GLAXOSMITHKLINE : reports positive Phase I trial results of Ebola vaccine candid..
1d ago GLAXOSMITHKLINE : Ebola Vaccine Progressing At "Unprecedented Rate"
1d ago NOVARTIS : GSK -Regulatory update on transaction with Novartis
1d ago NOVARTIS : FTC Puts Conditions on Pharmaceutical Joint Venture Between GlaxoSmit..
Advertisement
Chart
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | GSK | GB0009252882 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF